168 related articles for article (PubMed ID: 19301151)
1. Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis.
Kuncova K; Janda A; Kasal P; Zamecnik J
Pathol Oncol Res; 2009 Dec; 15(4):605-14. PubMed ID: 19301151
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
3. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K
Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872
[TBL] [Abstract][Full Text] [Related]
6. Prognostic marker analysis in pediatric intracranial ependymomas.
McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
8. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of cell cycle/apoptosis regulators and epidermal growth factor receptor in pediatric intracranial ependymomas.
Alexiou GA; Stefanaki K; Moschovi M; Patereli A; Prodromou N; Karentzou O
J Child Neurol; 2011 Feb; 26(2):195-8. PubMed ID: 20713981
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
Chen C; Chen L; Yao Y; Qin Z; Chen H
J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
Onguru O; Kurt B; Gunhan O; Soylemezoglu F
Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
[TBL] [Abstract][Full Text] [Related]
13. A study of proliferative markers and tumor suppressor gene proteins in different grades of ependymomas.
Sharma MC; Ghara N; Jain D; Sarkar C; Singh M; Mehta VS
Neuropathology; 2009 Apr; 29(2):148-55. PubMed ID: 18721229
[TBL] [Abstract][Full Text] [Related]
14. Apparent Diffusion Coefficient to Evaluate Adult Intracranial Ependymomas: Relationship to Ki-67 Proliferation Index.
Xianwang L; Lei H; Hong L; Juan D; Shenglin L; Caiqiang X; Yan H; Junlin Z
J Neuroimaging; 2021 Jan; 31(1):132-136. PubMed ID: 32961009
[TBL] [Abstract][Full Text] [Related]
15. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma.
Manasa LP; Uppin MS; Sundaram C
Indian J Pathol Microbiol; 2012; 55(3):308-13. PubMed ID: 23032822
[TBL] [Abstract][Full Text] [Related]
16. Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas.
Rushing EJ; Yashima K; Brown DF; White CL; Shay JW; Risser RC; Gazdar AF
J Neuropathol Exp Neurol; 1997 Oct; 56(10):1142-6. PubMed ID: 9329458
[TBL] [Abstract][Full Text] [Related]
17. Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis.
Verstegen MJ; Leenstra DT; Ijlst-Keizers H; Bosch DA
J Neurooncol; 2002 Jan; 56(1):21-8. PubMed ID: 11949823
[TBL] [Abstract][Full Text] [Related]
18. p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases.
Korshunov A; Golanov A; Timirgaz V
Acta Neuropathol; 2001 Sep; 102(3):271-7. PubMed ID: 11585252
[TBL] [Abstract][Full Text] [Related]
19. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.
Ridley L; Rahman R; Brundler MA; Ellison D; Lowe J; Robson K; Prebble E; Luckett I; Gilbertson RJ; Parkes S; Rand V; Coyle B; Grundy RG;
Neuro Oncol; 2008 Oct; 10(5):675-89. PubMed ID: 18701711
[TBL] [Abstract][Full Text] [Related]
20. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
